FDA Panel Says LASIK Merits Stronger Warnings

Law360, New York (April 29, 2008, 12:00 AM EDT) -- The U.S. Food and Drug Administration is reportedly planning to issue a stronger warning about the risks associated with the popular vision-correcting LASIK eye surgery following a panel meeting on Friday.

The FDA's Ophthalmic Devices Panel met on Friday to discuss LASIK's impact on patients' quality of life, the Associated Press and others reported.

Although a task force convened last year by the FDA and other agencies determined that 95.4% of LASIK patients are satisfied with their surgery, some patients report permanently distorted vision or eye...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.